Monaco Asset Management SAM »

Leap Therapeutics shares owned by Monaco Asset Management SAM

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Monaco Asset Management SAM from 13F filings

Historical chart of Monaco Asset Management SAM investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Monaco Asset Management SAM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Monaco Asset Management SAM

Quarter filed Position value Share count Share price at filing
2025-06-30 $312k 1.1M 0.30
2025-03-31 $320k 1.1M 0.31
2024-12-31 $592k 206k 2.88

More positions owned by Monaco Asset Management SAM

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Silver Tr Ishares Call Option (SLV)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Msci Brazil Etf Call Option (EWZ)
Microsoft Corporation Put Option (MSFT)
Costco Wholesale Corporation Put Option (COST)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
NVIDIA Corporation Put Option (NVDA)
Eli Lilly & Co. Put Option (LLY)
Viatris (VTRS)
AutoZone Put Option (AZO)
Patterson-UTI Energy (PTEN)
Vale S A Sponsored Ads (VALE)
Select Sector Spdr Tr Sbi Healthcare Put Option (XLV)
Lululemon Athletica (LULU)

View all positions for Monaco Asset Management SAM

Top funds holding Leap Therapeutics

Gilead Sciences
Acadian Asset Management
Vanguard Group
HighTower Advisors
Simplify Asset Management
Geode Capital Management
Jane Street
Key Client Fiduciary Advisors
State Street Corporation
BlackRock
Hrt Financial
Two Sigma Advisers
Susquehanna International
Citadel Advisors
Two Sigma Investments

View all funds holding Leap Therapeutics